CLINICAL_TRIALS
trial_result
· 2017-01-27
Clinical Trial Update: A Multicenter Study of NAP (AL-108) in Schizophrenia [Phase 2]
Summary
Phase 2 multicenter study evaluating NAP (AL-108) in schizophrenia completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Los Angeles | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2017-01-27